Your browser doesn't support javascript.
loading
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Roeker, Lindsey E; Eyre, Toby A; Thompson, Meghan C; Lamanna, Nicole; Coltoff, Alexander R; Davids, Matthew S; Baker, Peter O; Leslie, Lori; Rogers, Kerry A; Allan, John N; Cordoba, Raul; Lopez-Garcia, Alberto; Antic, Darko; Pagel, John M; Martinez-Calle, Nicolas; García-Marco, José Antonio; Hernández-Rivas, Jose-Ángel; Miras, Fatima; Coombs, Catherine C; Österborg, Anders; Hansson, Lotta; Seddon, Amanda N; López Jiménez, Javier; Wilson, Matthew R; El-Sharkawi, Dima; Wojenski, Daniel; Ma, Shuo; Munir, Talha; Valenciano, Susana; Seymour, Erlene; Barr, Paul M; Pu, Jeffrey; Patten, Piers E M; Perini, Guilherme F; Huntington, Scott F; Parry, Helen; Sundaram, Suchitra; Skarbnik, Alan; Kamdar, Manali; Jacobs, Ryan; Walter, Harriet; Walewska, Renata; Broom, Angus; Lebowitz, Sonia; Isaac, Krista M; Portell, Craig A; Ahn, Inhye E; Ujjani, Chaitra S; Shadman, Mazyar; Skånland, Sigrid S.
Afiliación
  • Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Eyre TA; Oxford University Hospitals, National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.
  • Thompson MC; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Lamanna N; Columbia University Medical Center, New York, NY.
  • Coltoff AR; Columbia University Medical Center, New York, NY.
  • Davids MS; Dana-Farber Cancer Institute, Boston, MA.
  • Baker PO; Dana-Farber Cancer Institute, Boston, MA.
  • Leslie L; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Rogers KA; The Ohio State University, Columbus, OH.
  • Allan JN; New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY.
  • Cordoba R; Fundacion Jimenez Diaz University Hospital, Madrid, Spain.
  • Lopez-Garcia A; Fundacion Jimenez Diaz University Hospital, Madrid, Spain.
  • Antic D; Clinical Center Serbia, University of Belgrade, Belgrade, Serbia.
  • Pagel JM; Swedish Cancer Institute, Seattle, WA.
  • Martinez-Calle N; Nottingham University Hospitals, NHS Trust, Nottingham, United Kingdom.
  • García-Marco JA; Hospital Puerta de Hierro Majadahonda, Madrid, Spain.
  • Hernández-Rivas JÁ; Hospital Infanta Leonor, Madrid, Spain.
  • Miras F; Hospital Doce de Octubre, Madrid, Spain.
  • Coombs CC; The University of North Carolina Cancer Center, Chapel Hill, NC.
  • Österborg A; Karolinska Institute, Solna, Sweden.
  • Hansson L; Karolinska Institute, Solna, Sweden.
  • Seddon AN; Rush University Medical Center, Chicago, IL.
  • López Jiménez J; Hospital Ramon y Cajal, Madrid, Spain.
  • Wilson MR; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • El-Sharkawi D; The Royal Marsden Hospital, London, United Kingdom.
  • Wojenski D; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.
  • Ma S; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.
  • Munir T; St James's University Hospital, Leeds, United Kingdom.
  • Valenciano S; Hospital Principe de Asturias, Alcala de Henares, Madrid, Spain.
  • Seymour E; Karmanos Cancer Institute, Wayne State University, Detroit, MI.
  • Barr PM; University of Rochester Wilmot Cancer Institute, Rochester, NY.
  • Pu J; Upstate Cancer Center, Syracuse, NY.
  • Patten PEM; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Science, King's College London, United Kingdom.
  • Perini GF; Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Huntington SF; Yale University, New Haven, CT.
  • Parry H; Medical and Dental Sciences, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Sundaram S; Roswell Park Cancer Institute, Buffalo, NY.
  • Skarbnik A; Novant Health, Charlotte, NC.
  • Kamdar M; University of Colorado Cancer Center, Aurora, CO.
  • Jacobs R; Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Walter H; Leicester Royal Infirmary, Leicester, United Kingdom.
  • Walewska R; Royal Bournemouth Hospital, Bournemouth, United Kingdom.
  • Broom A; Western General Hospital, Edinburgh, United Kingdom.
  • Lebowitz S; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Isaac KM; Emily Couric Clinical Cancer Center, Charlottesville, VA.
  • Portell CA; Emily Couric Clinical Cancer Center, Charlottesville, VA.
  • Ahn IE; National Heart, Lung, and Blood Institute, Bethesda, MD.
  • Ujjani CS; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Shadman M; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Skånland SS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University, Oslo, Norway; and.
Blood ; 138(18): 1768-1773, 2021 11 04.
Article en En | MEDLINE | ID: mdl-34297826
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos